Enlivex Ltd. SEC filings ENLV
Enlivex Ltd. has 419 filings in SEC EDGAR's recent list, going back to Feb 7, 2014. Its latest annual report, Form 20-F, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Aug 17, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 6, 2026 | — |
| 424B3 | Prospectus | May 1, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 21, 2026 | — |
| 424B3 | Prospectus | Mar 20, 2026 | — |
| S-8 | Employee stock plan registration | Mar 13, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Nov 24, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | May 2, 2025 | — |
| 424B5 | Prospectus supplement | May 29, 2024 | — |
| 424B5 | Prospectus supplement | Dec 30, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 29, 2022 | — |
| S-8 | Employee stock plan registration | Jun 4, 2021 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| FWP | Free writing prospectus | Feb 10, 2021 | — |
| F-3MEF | Registration statement | Feb 9, 2021 | — |
| FWP | Free writing prospectus | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Oct 22, 2020 | — |
| 424B5 | Prospectus supplement | Mar 3, 2020 | — |
| 424B5 | Prospectus supplement | Feb 26, 2020 | — |
| 424B5 | Prospectus supplement | Nov 20, 2019 | — |
| 424B3 | Prospectus | Jul 10, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 28, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 7, 2019 | — |
| F-1/A | Filing | Apr 6, 2017 | — |
| F-1/A | Amendment no. 3 | Apr 5, 2017 | — |
| F-1/A | Filing | Apr 4, 2017 | — |
| F-1/A | Filing | Mar 16, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Feb 24, 2017 | — |
| S-8 | Employee stock plan registration | Mar 29, 2016 | — |
| 424B5 | Prospectus supplement | Mar 18, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 3, 2015 | — |
| S-8 | Employee stock plan registration | Mar 31, 2015 | — |
| 424B4 | Prospectus | Jul 31, 2014 | — |
| F-1/A | Filing | Jul 25, 2014 | — |
| F-1/A | Filing | Jul 15, 2014 | — |
| F-1/A | Filing | Jul 8, 2014 | — |
| F-1/A | Form f-1/a | Apr 8, 2014 | — |
| F-1/A | Filing | Mar 17, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Feb 7, 2014 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- ENLV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1596812
- Former names
- Enlivex Therapeutics Ltd. (until Feb 10, 2026); Bioblast Pharma Ltd. (until Mar 18, 2019); BIO BLAST PHARMA LTD. (until Sep 12, 2016)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.